167.91
price down icon0.67%   -1.13
after-market  시간 외 거래:  167.91 
loading

Zoetis Inc 주식(ZTS)의 최신 뉴스

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech

pulisher
Seeking Alpha

4 Oversold Stocks to Buy Right Now

pulisher
The Motley Fool

Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?

pulisher
Zacks Investment Research

Zoetis (ZTS) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Why Zoetis Stock Popped by Almost 6% on Thursday

pulisher
The Motley Fool

Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?

pulisher
Benzinga

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

pulisher
Zacks Investment Research

Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates

pulisher
Zacks Investment Research

3 Blue-Chip Bargains Trading At 52-Week Lows

pulisher
Seeking Alpha

Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market

pulisher
Benzinga

1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation

pulisher
The Motley Fool

BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

pulisher
Zacks Investment Research

Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics

pulisher
Zacks Investment Research

Should You Invest in the VanEck Agribusiness ETF (MOO)?

pulisher
Zacks Investment Research

Wall Street Analysts Look Bullish on Zoetis (ZTS): Should You Buy?

pulisher
Zacks Investment Research

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

pulisher
Zacks Investment Research

Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

pulisher
Zacks Investment Research

Zoetis Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

pulisher
Benzinga

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

pulisher
Zacks Investment Research

Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis

pulisher
Benzinga

Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks

pulisher
Seeking Alpha

Zoetis (ZTS) Stock Moves -0.14%: What You Should Know

pulisher
Zacks Investment Research

Company News for Apr 15, 2024

pulisher
Zacks Investment Research

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

How's AT&T Handling Things?

pulisher
The Motley Fool

Why Zoetis (ZTS) Dipped More Than Broader Market Today

pulisher
Zacks Investment Research

Expert Outlook: Zoetis Through The Eyes Of 4 Analysts

pulisher
Benzinga

Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?

pulisher
The Motley Fool

More Big Changes To My Dividend Growth Portfolio

pulisher
Seeking Alpha

Zoetis (ZTS) Down 4.3% Since Last Earnings Report: Can It Rebound?

pulisher
Zacks Investment Research

Nvidia is no longer Wall Street’s favorite stock. This company is.

pulisher
MarketWatch

1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now

pulisher
The Motley Fool

Should You Invest in the VanEck Agribusiness ETF (MOO)?

pulisher
Zacks Investment Research

4 Analysts Have This To Say About Zoetis

pulisher
Benzinga

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

pulisher
Zacks Investment Research

GRFS or ZTS: Which Is the Better Value Stock Right Now?

pulisher
Zacks Investment Research

Company News for Feb 14, 2024

pulisher
Zacks Investment Research

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

pulisher
Zacks Investment Research

Zoetis (ZTS) Q4 2023 Earnings Call Transcript

pulisher
The Motley Fool

Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday?

pulisher
Benzinga

Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins

pulisher
Benzinga

Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat

pulisher
Zacks Investment Research

Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics

pulisher
Zacks Investment Research

Zoetis (ZTS) Q4 Earnings Lag Estimates

pulisher
Zacks Investment Research

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

pulisher
Zacks Investment Research

Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY

pulisher
Zacks Investment Research

Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?

pulisher
Zacks Investment Research

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

pulisher
Zacks Investment Research

Ahead of Zoetis (ZTS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

pulisher
Zacks Investment Research

Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know

pulisher
Zacks Investment Research
drug_manufacturers_specialty_generic TAK
$13.11
price down icon 1.06%
drug_manufacturers_specialty_generic HLN
$8.25
price up icon 0.12%
$16.88
price up icon 3.88%
$136.15
price down icon 0.40%
$11.36
price up icon 1.79%
자본화:     |  볼륨(24시간):